Farther Finance Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2K | Sell |
665
-34
| -5% | -$828 | ﹤0.01% | 2799 |
|
|
2025
Q1 | $14.1K | Buy |
699
+409
| +141% | +$8.26K | ﹤0.01% | 2561 |
|
|
2024
Q4 | $6.83K | Sell |
290
-10,360
| -97% | -$244K | ﹤0.01% | 2535 |
|
|
2024
Q3 | $273K | Sell |
10,650
-222
| -2% | -$5.68K | 0.01% | 869 |
|
|
2024
Q2 | $253K | Buy |
10,872
+1,481
| +16% | +$34.4K | 0.01% | 738 |
|
|
2024
Q1 | $266K | Buy |
9,391
+2,783
| +42% | +$78.9K | 0.02% | 589 |
|
|
2023
Q4 | $217K | Buy |
6,608
+4,680
| +243% | +$154K | 0.02% | 531 |
|
|
2023
Q3 | $53.7K | Hold |
1,928
| – | – | 0.01% | 751 |
|
|
2023
Q2 | $65.7K | Hold |
1,928
| – | – | 0.01% | 581 |
|
|
2023
Q1 | $58K | Hold |
1,928
| – | – | 0.02% | 569 |
|
|
2022
Q4 | $54.4K | Buy |
+1,928
| New | +$54.4K | 0.02% | 467 |
|